Skip to main content
Clinical Trials/NCT03507322
NCT03507322
Withdrawn
Not Applicable

Ultrasound Study Through Uterine Texturization to Predict Pregnancy After Blastocyst Transfer in Patients Undergoing Hormone Replacement Therapy (HRT) Cycles With Donor Oocytes

IVI Sevilla1 site in 1 countryNovember 7, 2017
ConditionsInfertility

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infertility
Sponsor
IVI Sevilla
Locations
1
Primary Endpoint
Chemical pregnancy rate
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

This study is focused on analysing the application of ultrasound scanning techniques as new biomarkers in reproductive medicine. Those biomarkers are based on the analysis of ultrasound texture in different areas of uterine tissue, using 2D/3D ultrasound scanning. Investigators will use the algorithm Text® to analyse the ultrasound texture of the endometrium and myometrium. The aim of the project is to study if it is possible to obtain measurable, objective and reproducible data in healthy volunteers which can be used to predict pregnancy and determine the best moment to perform embryo transfer in assisted reproductive technology (ART) cycles

Registry
clinicaltrials.gov
Start Date
November 7, 2017
End Date
September 10, 2018
Last Updated
7 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
IVI Sevilla
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Body mass index (BMI) between 18 and 30 kg/m2
  • Not taking the contraceptive pill in a previous cycle
  • Non-pregnant: beta human chorionic gonadotropin (HCG) test with negative result at the beginning of the study)
  • No previous history of inflammatory diseases, circulatory diseases, abdomen or pelvic diseases
  • Physical gynecological exploration without pathological findings
  • Gynecological ultrasound study of the uterus with a normal result

Exclusion Criteria

  • Ultrasound studies with technical defects in image acquisition
  • Simultaneous participation in other studies
  • Previous participation in other study which can affect the results of the present study

Outcomes

Primary Outcomes

Chemical pregnancy rate

Time Frame: Around 14 days after embryo transfer

Positive result in beta HCG test indicating pregnancy

Clinical miscarriage rate

Time Frame: Up to 20 weeks after embryo transfer

Interruption of pregnancy after confirming clinical pregnancy using ultrasound scanning

beta HCG level

Time Frame: Around 14 days after embryo transfer

Level of beta HCG in the test performed to detect pregnancy

Clinical pregnancy rate

Time Frame: Around 5-6 weeks after embryo transfer

Detection of gestational sac through ultrasound scanning indicating clinical pregnancy

Biochemical miscarriage rate

Time Frame: Up to one month after embryo transfer

Interruption of pregnancy after a positive result in the beta HCG test

Study Sites (1)

Loading locations...

Similar Trials